Searched for
CANCER DRUGS PROBLEM
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the state of the market these days, it would be wise to be selective. Not only in terms of stocks, but also in terms of sectors. For ...- How many Americans can afford high-quality healthcare? A new poll finds the number has fallenAmericans face growing challenges affording healthcare. New data reveals a significant drop in those able to manage medical costs and acces...
- The old health insurance model sees hospitalisation as an inconvenience, says Narayana Health's Viren Prasad Shetty; bets on managed care modelIt has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...
- India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
- Mark Zuckerberg's philanthropic venture unveils AI world model for drug discoveryBiohub, a venture by Mark Zuckerberg and Priscilla Chan, has launched a protein biology world model. This advanced AI tool aims to speed up...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Cancer burden rising, all hands on the deckIndia faces a critical shortage of cancer specialists. A new rule for the PMJAY scheme now bars experienced oncologists without specific de...
- Cancer drug makers seek 50% price hike as platinum surge hits production viabilityLocal drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...
- 'Can treat tumors that you cannot see'. Radiation drugs hunt & kill cancer cells, says new studyThe drug in this case is a molecule that contains two parts: a tracker and a cancer-killing payload.
- Ashwagandha may be drug candidate to treat aggressive cancerA number of studies in the recent past suggested that Withanolides, Withaferin-A and Withanone, have multi-modal anticancer activities, acc...
- With price cap, 22 drugs get cheaperThe price cap announced by National Pharmaceutical Pricing Authority (NPPA) would bring down maximum retail price or MRP of these medicines...
- Mitra Biotech, Harvard unravels how to kill cancer cells that avoid chemotherapyThe method was to give another common drug just when the cancer cells begin to morph into a stem-cell like type that can avoid the chemo dr...
- Major pharma-deals: How anti-cancer drugs are reshaping the pharmaceutical industryNew and considerable optimism over cancer drugs will drive deal-making in pharma over the decade, with companies weak in this segment tryin...
- Will continue selling Nexavar drug post IPAB verdict: Bhaskar Narayana, Natco PharmaIn an interview with ET Now, Bhaskar Narayana, Finance-Director, Natco Pharma, talks about the IPAB’s verdict on Natco’s cancer drug case a...
- Taking the toxin out of your cancer treatmentRA Sengupta and Shiladitya Mashelkar have set up a Delhi-based co, Invictus Oncology, to take a modified Cisplatin to the market.
- Govt may use compulsory licensing for drug companies only in emergencyThe government will not invoke CL unless the country is faced with an epidemic-like situation.
Load More
